These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 33115273)

  • 1. Genome-Wide Association Study Highlights
    Hoekstra M; Chen HY; Rong J; Dufresne L; Yao J; Guo X; Tsai MY; Tsimikas S; Post WS; Vasan RS; Rotter JI; Larson MG; Thanassoulis G; Engert JC
    Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):458-464. PubMed ID: 33115273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between lipoprotein(a) (Lp(a)) levels and Lp(a) genetic variants with coronary artery calcification.
    Pechlivanis S; Mahabadi AA; Hoffmann P; Nöthen MM; Broecker-Preuss M; Erbel R; Moebus S; Stang A; Jöckel KH
    BMC Med Genet; 2020 Mar; 21(1):62. PubMed ID: 32220223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-nucleotide polymorphisms in LPA explain most of the ancestry-specific variation in Lp(a) levels in African Americans.
    Deo RC; Wilson JG; Xing C; Lawson K; Kao WH; Reich D; Tandon A; Akylbekova E; Patterson N; Mosley TH; Boerwinkle E; Taylor HA
    PLoS One; 2011 Jan; 6(1):e14581. PubMed ID: 21283670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Long-term Exposure to Elevated Lipoprotein(a) Levels With Parental Life Span, Chronic Disease-Free Survival, and Mortality Risk: A Mendelian Randomization Analysis.
    Arsenault BJ; Pelletier W; Kaiser Y; Perrot N; Couture C; Khaw KT; Wareham NJ; Bossé Y; Pibarot P; Stroes ESG; Mathieu P; Thériault S; Boekholdt SM
    JAMA Netw Open; 2020 Feb; 3(2):e200129. PubMed ID: 32108890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide significant results identified for plasma apolipoprotein H levels in middle-aged and older adults.
    Mather KA; Thalamuthu A; Oldmeadow C; Song F; Armstrong NJ; Poljak A; Holliday EG; McEvoy M; Kwok JB; Assareh AA; Reppermund S; Kochan NA; Lee T; Ames D; Wright MJ; Trollor JN; Schofield PW; Brodaty H; Scott RJ; Schofield PR; Attia JR; Sachdev PS
    Sci Rep; 2016 Mar; 6():23675. PubMed ID: 27030319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variants associated with Lp(a) lipoprotein level and coronary disease.
    Clarke R; Peden JF; Hopewell JC; Kyriakou T; Goel A; Heath SC; Parish S; Barlera S; Franzosi MG; Rust S; Bennett D; Silveira A; Malarstig A; Green FR; Lathrop M; Gigante B; Leander K; de Faire U; Seedorf U; Hamsten A; Collins R; Watkins H; Farrall M;
    N Engl J Med; 2009 Dec; 361(26):2518-28. PubMed ID: 20032323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic Architecture of the Cardiovascular Risk Proteome.
    Benson MD; Yang Q; Ngo D; Zhu Y; Shen D; Farrell LA; Sinha S; Keyes MJ; Vasan RS; Larson MG; Smith JG; Wang TJ; Gerszten RE
    Circulation; 2018 Mar; 137(11):1158-1172. PubMed ID: 29258991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome- and exome-wide association study of serum lipoprotein (a) in the Jackson Heart Study.
    Li J; Lange LA; Sabourin J; Duan Q; Valdar W; Willis MS; Li Y; Wilson JG; Lange EM
    J Hum Genet; 2015 Dec; 60(12):755-61. PubMed ID: 26377243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of LPA Variants With Risk of Coronary Disease and the Implications for Lipoprotein(a)-Lowering Therapies: A Mendelian Randomization Analysis.
    Burgess S; Ference BA; Staley JR; Freitag DF; Mason AM; Nielsen SF; Willeit P; Young R; Surendran P; Karthikeyan S; Bolton TR; Peters JE; Kamstrup PR; Tybjærg-Hansen A; Benn M; Langsted A; Schnohr P; Vedel-Krogh S; Kobylecki CJ; Ford I; Packard C; Trompet S; Jukema JW; Sattar N; Di Angelantonio E; Saleheen D; Howson JMM; Nordestgaard BG; Butterworth AS; Danesh J;
    JAMA Cardiol; 2018 Jul; 3(7):619-627. PubMed ID: 29926099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel but frequent variant in LPA KIV-2 is associated with a pronounced Lp(a) and cardiovascular risk reduction.
    Coassin S; Erhart G; Weissensteiner H; Eca Guimarães de Araújo M; Lamina C; Schönherr S; Forer L; Haun M; Losso JL; Köttgen A; Schmidt K; Utermann G; Peters A; Gieger C; Strauch K; Finkenstedt A; Bale R; Zoller H; Paulweber B; Eckardt KU; Hüttenhofer A; Huber LA; Kronenberg F
    Eur Heart J; 2017 Jun; 38(23):1823-1831. PubMed ID: 28444229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ideal cardiovascular health influences cardiovascular disease risk associated with high lipoprotein(a) levels and genotype: The EPIC-Norfolk prospective population study.
    Perrot N; Verbeek R; Sandhu M; Boekholdt SM; Hovingh GK; Wareham NJ; Khaw KT; Arsenault BJ
    Atherosclerosis; 2017 Jan; 256():47-52. PubMed ID: 27998826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta analysis of candidate gene variants outside the LPA locus with Lp(a) plasma levels in 14,500 participants of six White European cohorts.
    Zabaneh D; Kumari M; Sandhu M; Wareham N; Wainwright N; Papamarkou T; Hopewell J; Clarke R; Li K; Palmen J; Talmud PJ; Kronenberg F; Lamina C; Summerer M; Paulweber B; Price J; Fowkes G; Stewart M; Drenos F; Shah S; Shah T; Casas JP; Kivimaki M; Whittaker J; Hingorani AD; Humphries SE
    Atherosclerosis; 2011 Aug; 217(2):447-51. PubMed ID: 21592478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex-Specific Associations of Genetically Predicted Circulating Lp(a) (Lipoprotein(a)) and Hepatic
    Guertin J; Kaiser Y; Manikpurage H; Perrot N; Bourgeois R; Couture C; Wareham NJ; Bossé Y; Pibarot P; Stroes ESG; Mathieu P; Clavel MA; Thériault S; Boekholdt SM; Arsenault BJ
    Circ Genom Precis Med; 2021 Aug; 14(4):e003271. PubMed ID: 34279996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic Variation in LPA, Calcific Aortic Valve Stenosis in Patients Undergoing Cardiac Surgery, and Familial Risk of Aortic Valve Microcalcification.
    Perrot N; Thériault S; Dina C; Chen HY; Boekholdt SM; Rigade S; Després AA; Poulin A; Capoulade R; Le Tourneau T; Messika-Zeitoun D; Trottier M; Tessier M; Guimond J; Nadeau M; Engert JC; Khaw KT; Wareham NJ; Dweck MR; Mathieu P; Pibarot P; Schott JJ; Thanassoulis G; Clavel MA; Bossé Y; Arsenault BJ
    JAMA Cardiol; 2019 Jul; 4(7):620-627. PubMed ID: 31141105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex and ethnic differences in the associations between lipoprotein(a) and peripheral arterial disease in the Multi-Ethnic Study of Atherosclerosis.
    Forbang NI; Criqui MH; Allison MA; Ix JH; Steffen BT; Cushman M; Tsai MY
    J Vasc Surg; 2016 Feb; 63(2):453-8. PubMed ID: 26518096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deep coverage whole genome sequences and plasma lipoprotein(a) in individuals of European and African ancestries.
    Zekavat SM; Ruotsalainen S; Handsaker RE; Alver M; Bloom J; Poterba T; Seed C; Ernst J; Chaffin M; Engreitz J; Peloso GM; Manichaikul A; Yang C; Ryan KA; Fu M; Johnson WC; Tsai M; Budoff M; Vasan RS; Cupples LA; Rotter JI; Rich SS; Post W; Mitchell BD; Correa A; Metspalu A; Wilson JG; Salomaa V; Kellis M; Daly MJ; Neale BM; McCarroll S; Surakka I; Esko T; Ganna A; Ripatti S; Kathiresan S; Natarajan P;
    Nat Commun; 2018 Jul; 9(1):2606. PubMed ID: 29973585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional Variant in the SLC22A3-LPAL2-LPA Gene Cluster Contributes to the Severity of Coronary Artery Disease.
    Wang L; Chen J; Zeng Y; Wei J; Jing J; Li G; Su L; Tang X; Wu T; Zhou L
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1989-96. PubMed ID: 27417586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide association study pinpoints a new functional apolipoprotein B variant influencing oxidized low-density lipoprotein levels but not cardiovascular events: AtheroRemo Consortium.
    Mäkelä KM; Seppälä I; Hernesniemi JA; Lyytikäinen LP; Oksala N; Kleber ME; Scharnagl H; Grammer TB; Baumert J; Thorand B; Jula A; Hutri-Kähönen N; Juonala M; Laitinen T; Laaksonen R; Karhunen PJ; Nikus KC; Nieminen T; Laurikka J; Kuukasjärvi P; Tarkka M; Viik J; Klopp N; Illig T; Kettunen J; Ahotupa M; Viikari JS; Kähönen M; Raitakari OT; Karakas M; Koenig W; Boehm BO; Winkelmann BR; März W; Lehtimäki T
    Circ Cardiovasc Genet; 2013 Feb; 6(1):73-81. PubMed ID: 23247145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations of Genetically Predicted Lp(a) (Lipoprotein [a]) Levels With Cardiovascular Traits in Individuals of European and African Ancestry.
    Satterfield BA; Dikilitas O; Safarova MS; Clarke SL; Tcheandjieu C; Zhu X; Bastarache L; Larson EB; Justice AE; Shang N; Rosenthal EA; Shah AS; Namjou-Khales B; Urbina EM; Wei WQ; Feng Q; Jarvik GP; Hebbring SJ; de Andrade M; Manolio TA; Assimes TL; Kullo IJ
    Circ Genom Precis Med; 2021 Aug; 14(4):e003354. PubMed ID: 34282949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide association study evaluating lipoprotein-associated phospholipase A2 mass and activity at baseline and after rosuvastatin therapy.
    Chu AY; Guilianini F; Grallert H; Dupuis J; Ballantyne CM; Barratt BJ; Nyberg F; Chasman DI; Ridker PM
    Circ Cardiovasc Genet; 2012 Dec; 5(6):676-85. PubMed ID: 23118302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.